Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

Author： Torp-Pedersen C.   Brendorp B.   Køber L.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.11, 2000-11, pp. : 2695-2704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent

By  

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 320-331

Karger

Access to resources Recommend Favorite

Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 573-579

Bentham Science Publishers

Access to resources Recommend Favorite

Azimilide dihydrochloride: a new class III anti-arrhythmic agent

By Abrol R.   Page R.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2705-2715

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Treatment of Atrial Fibrillation: Mechanisms of Action and Efficacy of Class III Drugs

By  

Current Medicinal Chemistry, Vol. 13, Iss. 14, 2006-06 ,pp. : 1635-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Antiarrhythmic drugs for atrial fibrillation

By Marinelli Alessandro   Capucci Alessandro  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1201-1215

Informa Healthcare

Access to resources Recommend Favorite